The article presents the review of 68 publications, recommendations, and guidelines on clinical trials of pretomanid for the treatment of patients with drug resistant tuberculosis. According to the publications, combinations of pretomanid with other anti-tuberculosis drugs are highly effective and promising in the treatment of such patients
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease. With g...
Abstract: Tuberculosis is the second leading cause of infectious deaths globally. Many effective con...
Tuberculosis (TB) remains the major health problem causing morbidity and mortality throughout the wo...
ABSTRACT: Tuberculosis (TB) is the leading infectious cause of mortality worldwide. Despite the deve...
Concerns regarding the rise of drug-resistant tuberculosis (DR-TB) infections and the need for new d...
Coronavirus disease (COVID-19) pandemic determined a 10 years-set back in tuberculosis (TB) control ...
WOS:000428154600001In 2015, the World Health Organization registered 10.4 million people who develop...
Tuberculosis (TB), an ongoing public health threat, is worsened by the emergence of drug resistance....
The article analyzes scientific publications (37 articles) devoted to phthisiology, clinical pharmac...
The management of multidrug-resistant tuberculosis (TB) is associated with low treatment success, hi...
Drug-resistant tuberculosis (DR-TB) has been an area of growing concern and posing threat to human h...
ABSTRACT Multidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respect...
Tuberculosis remains the world's leading cause of death from an infectious disease, responsible for ...
The article presents a clinical case of effective treatment of a female patient suffering from respi...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising f...
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease. With g...
Abstract: Tuberculosis is the second leading cause of infectious deaths globally. Many effective con...
Tuberculosis (TB) remains the major health problem causing morbidity and mortality throughout the wo...
ABSTRACT: Tuberculosis (TB) is the leading infectious cause of mortality worldwide. Despite the deve...
Concerns regarding the rise of drug-resistant tuberculosis (DR-TB) infections and the need for new d...
Coronavirus disease (COVID-19) pandemic determined a 10 years-set back in tuberculosis (TB) control ...
WOS:000428154600001In 2015, the World Health Organization registered 10.4 million people who develop...
Tuberculosis (TB), an ongoing public health threat, is worsened by the emergence of drug resistance....
The article analyzes scientific publications (37 articles) devoted to phthisiology, clinical pharmac...
The management of multidrug-resistant tuberculosis (TB) is associated with low treatment success, hi...
Drug-resistant tuberculosis (DR-TB) has been an area of growing concern and posing threat to human h...
ABSTRACT Multidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respect...
Tuberculosis remains the world's leading cause of death from an infectious disease, responsible for ...
The article presents a clinical case of effective treatment of a female patient suffering from respi...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising f...
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease. With g...
Abstract: Tuberculosis is the second leading cause of infectious deaths globally. Many effective con...
Tuberculosis (TB) remains the major health problem causing morbidity and mortality throughout the wo...